Pre-order Enquiry
Request Free Sample
Global Cell-Free DNA (cfDNA) Testing Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
SKU ID : QYR-22005379 | Publishing Date : 11-Nov-2022 | No. of pages : 110
Detailed TOC of Global Cell-Free DNA (cfDNA) Testing Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell-Free DNA (cfDNA) Testing Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Donor-Derived Cell-Free DNA (DdcfDNA)
1.2.3 Circulating Cell-Free Tumor DNA (CtDNA)
1.2.4 Cell-Free Fetal DNA (NIPT)
1.3 Market by Application
1.3.1 Global Cell-Free DNA (cfDNA) Testing Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Ambulatory Surgical Centers
1.3.4 Cancer Research Institutes
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Cell-Free DNA (cfDNA) Testing Market Size (2017-2028)
2.2 Cell-Free DNA (cfDNA) Testing Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Cell-Free DNA (cfDNA) Testing Market Size by Region (2017-2022)
2.4 Global Cell-Free DNA (cfDNA) Testing Market Size Forecast by Region (2023-2028)
2.5 Global Top Cell-Free DNA (cfDNA) Testing Countries Ranking by Market Size
3 Cell-Free DNA (cfDNA) Testing Competitive by Company
3.1 Global Cell-Free DNA (cfDNA) Testing Revenue by Players
3.1.1 Global Cell-Free DNA (cfDNA) Testing Revenue by Players (2017-2022)
3.1.2 Global Cell-Free DNA (cfDNA) Testing Market Share by Players (2017-2022)
3.2 Global Cell-Free DNA (cfDNA) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Cell-Free DNA (cfDNA) Testing Revenue
3.4 Global Cell-Free DNA (cfDNA) Testing Market Concentration Ratio
3.4.1 Global Cell-Free DNA (cfDNA) Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell-Free DNA (cfDNA) Testing Revenue in 2021
3.5 Global Cell-Free DNA (cfDNA) Testing Key Players Head office and Area Served
3.6 Key Players Cell-Free DNA (cfDNA) Testing Product Solution and Service
3.7 Date of Enter into Cell-Free DNA (cfDNA) Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Cell-Free DNA (cfDNA) Testing Breakdown Data by Type
4.1 Global Cell-Free DNA (cfDNA) Testing Historic Revenue by Type (2017-2022)
4.2 Global Cell-Free DNA (cfDNA) Testing Forecasted Revenue by Type (2023-2028)
5 Global Cell-Free DNA (cfDNA) Testing Breakdown Data by Application
5.1 Global Cell-Free DNA (cfDNA) Testing Historic Market Size by Application (2017-2022)
5.2 Global Cell-Free DNA (cfDNA) Testing Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Cell-Free DNA (cfDNA) Testing Revenue by Company (2020-2022)
6.2 North America Cell-Free DNA (cfDNA) Testing Revenue by Type (2017-2028)
6.3 North America Cell-Free DNA (cfDNA) Testing Revenue by Application (2017-2028)
6.4 North America Cell-Free DNA (cfDNA) Testing Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Cell-Free DNA (cfDNA) Testing Revenue by Company (2020-2022)
7.2 Europe Cell-Free DNA (cfDNA) Testing Revenue by Type (2017-2028)
7.3 Europe Cell-Free DNA (cfDNA) Testing Revenue by Application (2017-2028)
7.4 Europe Cell-Free DNA (cfDNA) Testing Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Cell-Free DNA (cfDNA) Testing Revenue by Company (2020-2022)
8.2 Asia Pacific Cell-Free DNA (cfDNA) Testing Revenue by Type (2017-2028)
8.3 Asia Pacific Cell-Free DNA (cfDNA) Testing Revenue by Application (2017-2028)
8.4 Asia Pacific Cell-Free DNA (cfDNA) Testing Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Cell-Free DNA (cfDNA) Testing Revenue by Company (2020-2022)
9.2 Latin America Cell-Free DNA (cfDNA) Testing Revenue by Type (2017-2028)
9.3 Latin America Cell-Free DNA (cfDNA) Testing Revenue by Application (2017-2028)
9.4 Latin America Cell-Free DNA (cfDNA) Testing Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Cell-Free DNA (cfDNA) Testing Revenue by Company (2020-2022)
10.2 Middle East and Africa Cell-Free DNA (cfDNA) Testing Revenue by Type (2017-2028)
10.3 Middle East and Africa Cell-Free DNA (cfDNA) Testing Revenue by Application (2017-2028)
10.4 Middle East and Africa Cell-Free DNA (cfDNA) Testing Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 U.A.E
11 Company Profiles
11.1 Agilent Technology
11.1.1 Agilent Technology Company Details
11.1.2 Agilent Technology Business Overview
11.1.3 Agilent Technology Cell-Free DNA (cfDNA) Testing Products and Services
11.1.4 Agilent Technology Cell-Free DNA (cfDNA) Testing Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
11.1.5 Agilent Technology Cell-Free DNA (cfDNA) Testing SWOT Analysis
11.1.6 Agilent Technology Recent Developments
11.2 Allenex
11.2.1 Allenex Company Details
11.2.2 Allenex Business Overview
11.2.3 Allenex Cell-Free DNA (cfDNA) Testing Products and Services
11.2.4 Allenex Cell-Free DNA (cfDNA) Testing Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
11.2.5 Allenex Cell-Free DNA (cfDNA) Testing SWOT Analysis
11.2.6 Allenex Recent Developments
11.3 Biocept
11.3.1 Biocept Company Details
11.3.2 Biocept Business Overview
11.3.3 Biocept Cell-Free DNA (cfDNA) Testing Products and Services
11.3.4 Biocept Cell-Free DNA (cfDNA) Testing Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
11.3.5 Biocept Cell-Free DNA (cfDNA) Testing SWOT Analysis
11.3.6 Biocept Recent Developments
11.4 Biodesix
11.4.1 Biodesix Company Details
11.4.2 Biodesix Business Overview
11.4.3 Biodesix Cell-Free DNA (cfDNA) Testing Products and Services
11.4.4 Biodesix Cell-Free DNA (cfDNA) Testing Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
11.4.5 Biodesix Cell-Free DNA (cfDNA) Testing SWOT Analysis
11.4.6 Biodesix Recent Developments
11.5 CareDx
11.5.1 CareDx Company Details
11.5.2 CareDx Business Overview
11.5.3 CareDx Cell-Free DNA (cfDNA) Testing Products and Services
11.5.4 CareDx Cell-Free DNA (cfDNA) Testing Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
11.5.5 CareDx Cell-Free DNA (cfDNA) Testing SWOT Analysis
11.5.6 CareDx Recent Developments
11.6 Guardant Health
11.6.1 Guardant Health Company Details
11.6.2 Guardant Health Business Overview
11.6.3 Guardant Health Cell-Free DNA (cfDNA) Testing Products and Services
11.6.4 Guardant Health Cell-Free DNA (cfDNA) Testing Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
11.6.5 Guardant Health Cell-Free DNA (cfDNA) Testing SWOT Analysis
11.6.6 Guardant Health Recent Developments
11.7 Illumania
11.7.1 Illumania Company Details
11.7.2 Illumania Business Overview
11.7.3 Illumania Cell-Free DNA (cfDNA) Testing Products and Services
11.7.4 Illumania Cell-Free DNA (cfDNA) Testing Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
11.7.5 Illumania Cell-Free DNA (cfDNA) Testing SWOT Analysis
11.7.6 Illumania Recent Developments
11.8 Invited
11.8.1 Invited Company Details
11.8.2 Invited Business Overview
11.8.3 Invited Cell-Free DNA (cfDNA) Testing Products and Services
11.8.4 Invited Cell-Free DNA (cfDNA) Testing Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
11.8.5 Invited Cell-Free DNA (cfDNA) Testing SWOT Analysis
11.8.6 Invited Recent Developments
11.9 Natera
11.9.1 Natera Company Details
11.9.2 Natera Business Overview
11.9.3 Natera Cell-Free DNA (cfDNA) Testing Products and Services
11.9.4 Natera Cell-Free DNA (cfDNA) Testing Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
11.9.5 Natera Cell-Free DNA (cfDNA) Testing SWOT Analysis
11.9.6 Natera Recent Developments
11.10 Quest Diagnostics
11.10.1 Quest Diagnostics Company Details
11.10.2 Quest Diagnostics Business Overview
11.10.3 Quest Diagnostics Cell-Free DNA (cfDNA) Testing Products and Services
11.10.4 Quest Diagnostics Cell-Free DNA (cfDNA) Testing Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
11.10.5 Quest Diagnostics Cell-Free DNA (cfDNA) Testing SWOT Analysis
11.10.6 Quest Diagnostics Recent Developments
11.11 Roche Holdings
11.11.1 Roche Holdings Company Details
11.11.2 Roche Holdings Business Overview
11.11.3 Roche Holdings Cell-Free DNA (cfDNA) Testing Products and Services
11.11.4 Roche Holdings Cell-Free DNA (cfDNA) Testing Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
11.11.5 Roche Holdings Recent Developments
11.12 Sequenom
11.12.1 Sequenom Company Details
11.12.2 Sequenom Business Overview
11.12.3 Sequenom Cell-Free DNA (cfDNA) Testing Products and Services
11.12.4 Sequenom Cell-Free DNA (cfDNA) Testing Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
11.12.5 Sequenom Recent Developments
11.13 Trovagene
11.13.1 Trovagene Company Details
11.13.2 Trovagene Business Overview
11.13.3 Trovagene Cell-Free DNA (cfDNA) Testing Products and Services
11.13.4 Trovagene Cell-Free DNA (cfDNA) Testing Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
11.13.5 Trovagene Recent Developments
12 Cell-Free DNA (cfDNA) Testing Market Dynamics
12.1 Cell-Free DNA (cfDNA) Testing Market Trends
12.2 Cell-Free DNA (cfDNA) Testing Market Drivers
12.3 Cell-Free DNA (cfDNA) Testing Market Challenges
12.4 Cell-Free DNA (cfDNA) Testing Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of Figures, Tables and Charts Available in Global Cell-Free DNA (cfDNA) Testing Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
List of TablesTable 1. Global Cell-Free DNA (cfDNA) Testing Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Donor-Derived Cell-Free DNA (DdcfDNA)
Table 3. Key Players of Circulating Cell-Free Tumor DNA (CtDNA)
Table 4. Key Players of Cell-Free Fetal DNA (NIPT)
Table 5. Global Cell-Free DNA (cfDNA) Testing Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Cell-Free DNA (cfDNA) Testing Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 7. Global Cell-Free DNA (cfDNA) Testing Revenue by Region (2017-2022) & (US$ Million)
Table 8. Global Cell-Free DNA (cfDNA) Testing Revenue Market Share by Region (2017-2022)
Table 9. Global Cell-Free DNA (cfDNA) Testing Revenue by Players (2017-2022) & (US$ Million)
Table 10. Global Cell-Free DNA (cfDNA) Testing Market Share by Players (2017-2022)
Table 11. Global Top Cell-Free DNA (cfDNA) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell-Free DNA (cfDNA) Testing as of 2021)
Table 12. Ranking of Global Top Cell-Free DNA (cfDNA) Testing Companies by Revenue (US$ Million) in 2021
Table 13. Global 5 Largest Players Market Share by Cell-Free DNA (cfDNA) Testing Revenue (CR5 and HHI) & (2017-2022)
Table 14. Key Players Headquarters and Area Served
Table 15. Key Players Cell-Free DNA (cfDNA) Testing Product Solution and Service
Table 16. Date of Key Manufacturers Enter into Cell-Free DNA (cfDNA) Testing Market
Table 17. Mergers & Acquisitions, Expansion Plans
Table 18. Global Cell-Free DNA (cfDNA) Testing Market Size by Type (2017-2022) & (US$ Million)
Table 19. Global Cell-Free DNA (cfDNA) Testing Revenue Market Share by Type (2017-2022)
Table 20. Global Cell-Free DNA (cfDNA) Testing Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 21. Global Cell-Free DNA (cfDNA) Testing Revenue Market Share by Type (2023-2028)
Table 22. Global Cell-Free DNA (cfDNA) Testing Market Size by Application (2017-2022) & (US$ Million)
Table 23. Global Cell-Free DNA (cfDNA) Testing Revenue Market Share by Application (2017-2022)
Table 24. Global Cell-Free DNA (cfDNA) Testing Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 25. Global Cell-Free DNA (cfDNA) Testing Revenue Market Share by Application (2023-2028)
Table 26. North America Cell-Free DNA (cfDNA) Testing Revenue by Company (2020-2022) & (US$ Million)
Table 27. North America Cell-Free DNA (cfDNA) Testing Revenue by Type (2017-2022) & (US$ Million)
Table 28. North America Cell-Free DNA (cfDNA) Testing Revenue by Type (2023-2028) & (US$ Million)
Table 29. North America Cell-Free DNA (cfDNA) Testing Revenue by Application (2017-2022) & (US$ Million)
Table 30. North America Cell-Free DNA (cfDNA) Testing Revenue by Application (2023-2028) & (US$ Million)
Table 31. North America Cell-Free DNA (cfDNA) Testing Revenue by Country (2017-2022) & (US$ Million)
Table 32. North America Cell-Free DNA (cfDNA) Testing Revenue by Country (2023-2028) & (US$ Million)
Table 33. Europe Cell-Free DNA (cfDNA) Testing Revenue by Company (2020-2022) & (US$ Million)
Table 34. Europe Cell-Free DNA (cfDNA) Testing Revenue by Type (2017-2022) & (US$ Million)
Table 35. Europe Cell-Free DNA (cfDNA) Testing Revenue by Type (2023-2028) & (US$ Million)
Table 36. Europe Cell-Free DNA (cfDNA) Testing Revenue by Application (2017-2022) & (US$ Million)
Table 37. Europe Cell-Free DNA (cfDNA) Testing Revenue by Application (2023-2028) & (US$ Million)
Table 38. Europe Cell-Free DNA (cfDNA) Testing Revenue by Country (2017-2022) & (US$ Million)
Table 39. Europe Cell-Free DNA (cfDNA) Testing Revenue by Country (2023-2028) & (US$ Million)
Table 40. Asia Pacific Cell-Free DNA (cfDNA) Testing Revenue by Company (2020-2022) & (US$ Million)
Table 41. Asia Pacific Cell-Free DNA (cfDNA) Testing Revenue by Type (2017-2022) & (US$ Million)
Table 42. Asia Pacific Cell-Free DNA (cfDNA) Testing Revenue by Type (2023-2028) & (US$ Million)
Table 43. Asia Pacific Cell-Free DNA (cfDNA) Testing Revenue by Application (2017-2022) & (US$ Million)
Table 44. Asia Pacific Cell-Free DNA (cfDNA) Testing Revenue by Application (2023-2028) & (US$ Million)
Table 45. Asia Pacific Cell-Free DNA (cfDNA) Testing Revenue by Region (2017-2022) & (US$ Million)
Table 46. Asia Pacific Cell-Free DNA (cfDNA) Testing Revenue by Region (2023-2028) & (US$ Million)
Table 47. Latin America Cell-Free DNA (cfDNA) Testing Revenue by Company (2020-2022) & (US$ Million)
Table 48. Latin America Cell-Free DNA (cfDNA) Testing Revenue by Type (2017-2022) & (US$ Million)
Table 49. Latin America Cell-Free DNA (cfDNA) Testing Revenue by Type (2023-2028) & (US$ Million)
Table 50. Latin America Cell-Free DNA (cfDNA) Testing Revenue by Application (2017-2022) & (US$ Million)
Table 51. Latin America Cell-Free DNA (cfDNA) Testing Revenue by Application (2023-2028) & (US$ Million)
Table 52. Latin America Cell-Free DNA (cfDNA) Testing Revenue by Country (2017-2022) & (US$ Million)
Table 53. Latin America Cell-Free DNA (cfDNA) Testing Revenue by Country (2023-2028) & (US$ Million)
Table 54. Middle East and Africa Cell-Free DNA (cfDNA) Testing Revenue by Company (2020-2022) & (US$ Million)
Table 55. Middle East and Africa Cell-Free DNA (cfDNA) Testing Revenue by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Cell-Free DNA (cfDNA) Testing Revenue by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Cell-Free DNA (cfDNA) Testing Revenue by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Cell-Free DNA (cfDNA) Testing Revenue by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Cell-Free DNA (cfDNA) Testing Revenue by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Cell-Free DNA (cfDNA) Testing Revenue by Country (2023-2028) & (US$ Million)
Table 61. Agilent Technology Company Details
Table 62. Agilent Technology Business Overview
Table 63. Agilent Technology Cell-Free DNA (cfDNA) Testing Product and Services
Table 64. Agilent Technology Cell-Free DNA (cfDNA) Testing Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) & (US$ Million)
Table 65. Agilent Technology Cell-Free DNA (cfDNA) Testing SWOT Analysis
Table 66. Agilent Technology Recent Developments
Table 67. Allenex Company Details
Table 68. Allenex Business Overview
Table 69. Allenex Cell-Free DNA (cfDNA) Testing Product and Services
Table 70. Allenex Cell-Free DNA (cfDNA) Testing Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) & (US$ Million)
Table 71. Allenex Cell-Free DNA (cfDNA) Testing SWOT Analysis
Table 72. Allenex Recent Developments
Table 73. Biocept Company Details
Table 74. Biocept Business Overview
Table 75. Biocept Cell-Free DNA (cfDNA) Testing Product and Services
Table 76. Biocept Cell-Free DNA (cfDNA) Testing Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) & (US$ Million)
Table 77. Biocept Cell-Free DNA (cfDNA) Testing SWOT Analysis
Table 78. Biocept Recent Developments
Table 79. Biodesix Company Details
Table 80. Biodesix Business Overview
Table 81. Biodesix Cell-Free DNA (cfDNA) Testing Product and Services
Table 82. Biodesix Cell-Free DNA (cfDNA) Testing Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) & (US$ Million)
Table 83. Biodesix Cell-Free DNA (cfDNA) Testing SWOT Analysis
Table 84. Biodesix Recent Developments
Table 85. CareDx Company Details
Table 86. CareDx Business Overview
Table 87. CareDx Cell-Free DNA (cfDNA) Testing Product and Services
Table 88. CareDx Cell-Free DNA (cfDNA) Testing Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) & (US$ Million)
Table 89. CareDx Cell-Free DNA (cfDNA) Testing SWOT Analysis
Table 90. CareDx Recent Developments
Table 91. Guardant Health Company Details
Table 92. Guardant Health Business Overview
Table 93. Guardant Health Cell-Free DNA (cfDNA) Testing Product and Services
Table 94. Guardant Health Cell-Free DNA (cfDNA) Testing Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) & (US$ Million)
Table 95. Guardant Health Cell-Free DNA (cfDNA) Testing SWOT Analysis
Table 96. Guardant Health Recent Developments
Table 97. Illumania Company Details
Table 98. Illumania Business Overview
Table 99. Illumania Cell-Free DNA (cfDNA) Testing Product and Services
Table 100. Illumania Cell-Free DNA (cfDNA) Testing Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) & (US$ Million)
Table 101. Illumania Cell-Free DNA (cfDNA) Testing SWOT Analysis
Table 102. Illumania Recent Developments
Table 103. Invited Company Details
Table 104. Invited Business Overview
Table 105. Invited Cell-Free DNA (cfDNA) Testing Product and Services
Table 106. Invited Cell-Free DNA (cfDNA) Testing Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) & (US$ Million)
Table 107. Invited Cell-Free DNA (cfDNA) Testing SWOT Analysis
Table 108. Invited Recent Developments
Table 109. Natera Company Details
Table 110. Natera Business Overview
Table 111. Natera Cell-Free DNA (cfDNA) Testing Product and Services
Table 112. Natera Cell-Free DNA (cfDNA) Testing Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) & (US$ Million)
Table 113. Natera Cell-Free DNA (cfDNA) Testing SWOT Analysis
Table 114. Natera Recent Developments
Table 115. Quest Diagnostics Company Details
Table 116. Quest Diagnostics Business Overview
Table 117. Quest Diagnostics Cell-Free DNA (cfDNA) Testing Product and Services
Table 118. Quest Diagnostics Cell-Free DNA (cfDNA) Testing Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) & (US$ Million)
Table 119. Quest Diagnostics Cell-Free DNA (cfDNA) Testing SWOT Analysis
Table 120. Quest Diagnostics Recent Developments
Table 121. Roche Holdings Company Details
Table 122. Roche Holdings Business Overview
Table 123. Roche Holdings Cell-Free DNA (cfDNA) Testing Product and Services
Table 124. Roche Holdings Cell-Free DNA (cfDNA) Testing Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) & (US$ Million)
Table 125. Roche Holdings Recent Developments
Table 126. Sequenom Company Details
Table 127. Sequenom Business Overview
Table 128. Sequenom Cell-Free DNA (cfDNA) Testing Product and Services
Table 129. Sequenom Cell-Free DNA (cfDNA) Testing Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) & (US$ Million)
Table 130. Sequenom Recent Developments
Table 131. Trovagene Company Details
Table 132. Trovagene Business Overview
Table 133. Trovagene Cell-Free DNA (cfDNA) Testing Product and Services
Table 134. Trovagene Cell-Free DNA (cfDNA) Testing Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) & (US$ Million)
Table 135. Trovagene Recent Developments
Table 136. Cell-Free DNA (cfDNA) Testing Market Trends
Table 137. Cell-Free DNA (cfDNA) Testing Market Drivers
Table 138. Cell-Free DNA (cfDNA) Testing Market Challenges
Table 139. Cell-Free DNA (cfDNA) Testing Market Restraints
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cell-Free DNA (cfDNA) Testing Sales Market Share by Type: 2021 VS 2028
Figure 2. Donor-Derived Cell-Free DNA (DdcfDNA) Features
Figure 3. Circulating Cell-Free Tumor DNA (CtDNA) Features
Figure 4. Cell-Free Fetal DNA (NIPT) Features
Figure 5. Global Cell-Free DNA (cfDNA) Testing Sales Market Share by Application: 2021 VS 2028
Figure 6. Hospital Case Studies
Figure 7. Ambulatory Surgical Centers Case Studies
Figure 8. Cancer Research Institutes Case Studies
Figure 9. Cell-Free DNA (cfDNA) Testing Report Years Considered
Figure 10. Global Cell-Free DNA (cfDNA) Testing Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Cell-Free DNA (cfDNA) Testing Market Size 2017-2028 (US$ Million)
Figure 12. Global Cell-Free DNA (cfDNA) Testing Market Size Market Share by Region: 2021 VS 2028
Figure 13. Global Cell-Free DNA (cfDNA) Testing Revenue Market Share by Region in 2017 VS 2022
Figure 14. Global Top 10 Cell-Free DNA (cfDNA) Testing Countries Ranking by Market Size (US$ Million) in 2021
Figure 15. Global Cell-Free DNA (cfDNA) Testing Market Share by Players in 2021
Figure 16. Global Top Cell-Free DNA (cfDNA) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell-Free DNA (cfDNA) Testing as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Cell-Free DNA (cfDNA) Testing Revenue in 2021
Figure 18. North America Cell-Free DNA (cfDNA) Testing Revenue Market Share by Company in 2021
Figure 19. North America Cell-Free DNA (cfDNA) Testing Revenue Market Share by Type (2017-2028)
Figure 20. North America Cell-Free DNA (cfDNA) Testing Revenue Market Share by Application (2017-2028)
Figure 21. North America Cell-Free DNA (cfDNA) Testing Revenue Share by Country (2017-2028)
Figure 22. U.S. Cell-Free DNA (cfDNA) Testing Revenue (2017-2028) & (US$ Million)
Figure 23. Canada Cell-Free DNA (cfDNA) Testing Revenue (2017-2028) & (US$ Million)
Figure 24. Europe Cell-Free DNA (cfDNA) Testing Revenue Market Share by Company in 2021
Figure 25. Europe Cell-Free DNA (cfDNA) Testing Revenue Market Share by Type (2017-2028)
Figure 26. Europe Cell-Free DNA (cfDNA) Testing Revenue Market Share by Application (2017-2028)
Figure 27. Europe Cell-Free DNA (cfDNA) Testing Revenue Share by Country (2017-2028)
Figure 28. Germany Cell-Free DNA (cfDNA) Testing Revenue (2017-2028) & (US$ Million)
Figure 29. France Cell-Free DNA (cfDNA) Testing Revenue (2017-2028) & (US$ Million)
Figure 30. U.K. Cell-Free DNA (cfDNA) Testing Revenue (2017-2028) & (US$ Million)
Figure 31. Italy Cell-Free DNA (cfDNA) Testing Revenue (2017-2028) & (US$ Million)
Figure 32. Russia Cell-Free DNA (cfDNA) Testing Revenue (2017-2028) & (US$ Million)
Figure 33. Asia Pacific Cell-Free DNA (cfDNA) Testing Revenue Market Share by Company in 2021
Figure 34. Asia Pacific Cell-Free DNA (cfDNA) Testing Revenue Market Share by Type (2017-2028)
Figure 35. Asia Pacific Cell-Free DNA (cfDNA) Testing Revenue Market Share by Application (2017-2028)
Figure 36. Asia Pacific Cell-Free DNA (cfDNA) Testing Revenue Share by Region (2017-2028)
Figure 37. China Cell-Free DNA (cfDNA) Testing Revenue (2017-2028) & (US$ Million)
Figure 38. Japan Cell-Free DNA (cfDNA) Testing Revenue (2017-2028) & (US$ Million)
Figure 39. South Korea Cell-Free DNA (cfDNA) Testing Revenue (2017-2028) & (US$ Million)
Figure 40. India Cell-Free DNA (cfDNA) Testing Revenue (2017-2028) & (US$ Million)
Figure 41. Australia Cell-Free DNA (cfDNA) Testing Revenue (2017-2028) & (US$ Million)
Figure 42. Taiwan Cell-Free DNA (cfDNA) Testing Revenue (2017-2028) & (US$ Million)
Figure 43. Indonesia Cell-Free DNA (cfDNA) Testing Revenue (2017-2028) & (US$ Million)
Figure 44. Thailand Cell-Free DNA (cfDNA) Testing Revenue (2017-2028) & (US$ Million)
Figure 45. Malaysia Cell-Free DNA (cfDNA) Testing Revenue (2017-2028) & (US$ Million)
Figure 46. Philippines Cell-Free DNA (cfDNA) Testing Revenue (2017-2028) & (US$ Million)
Figure 47. Vietnam Cell-Free DNA (cfDNA) Testing Revenue (2017-2028) & (US$ Million)
Figure 48. Latin America Cell-Free DNA (cfDNA) Testing Revenue Market Share by Company in 2021
Figure 49. Latin America Cell-Free DNA (cfDNA) Testing Revenue Market Share by Type (2017-2028)
Figure 50. Latin America Cell-Free DNA (cfDNA) Testing Revenue Market Share by Application (2017-2028)
Figure 51. Latin America Cell-Free DNA (cfDNA) Testing Revenue Share by Country (2017-2028)
Figure 52. Mexico Cell-Free DNA (cfDNA) Testing Revenue (2017-2028) & (US$ Million)
Figure 53. Brazil Cell-Free DNA (cfDNA) Testing Revenue (2017-2028) & (US$ Million)
Figure 54. Argentina Cell-Free DNA (cfDNA) Testing Revenue (2017-2028) & (US$ Million)
Figure 55. Middle East and Africa Cell-Free DNA (cfDNA) Testing Revenue Market Share by Company in 2021
Figure 56. Middle East and Africa Cell-Free DNA (cfDNA) Testing Revenue Market Share by Type (2017-2028)
Figure 57. Middle East and Africa Cell-Free DNA (cfDNA) Testing Revenue Market Share by Application (2017-2028)
Figure 58. Middle East and Africa Cell-Free DNA (cfDNA) Testing Revenue Share by Country (2017-2028)
Figure 59. Turkey Cell-Free DNA (cfDNA) Testing Revenue (2017-2028) & (US$ Million)
Figure 60. Saudi Arabia Cell-Free DNA (cfDNA) Testing Revenue (2017-2028) & (US$ Million)
Figure 61. U.A.E Cell-Free DNA (cfDNA) Testing Revenue (2017-2028) & (US$ Million)
Figure 62. Agilent Technology Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
Figure 63. Allenex Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
Figure 64. Biocept Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
Figure 65. Biodesix Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
Figure 66. CareDx Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
Figure 67. Guardant Health Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
Figure 68. Illumania Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
Figure 69. Invited Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
Figure 70. Natera Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
Figure 71. Quest Diagnostics Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
Figure 72. Roche Holdings Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
Figure 73. Sequenom Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
Figure 74. Trovagene Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed
Keyplayers in Global Cell-Free DNA (cfDNA) Testing Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
Agilent TechnologyAllenex
Biocept
Biodesix
CareDx
Guardant Health
Illumania
Invited
Natera
Quest Diagnostics
Roche Holdings
Sequenom
Trovagene
Request Sample
Request Discount
